This study assessed the effect of gender, diabetic status, statin use, smoking, hypertension, cardiac status, and use of cilostazol on the outcome of a supervised exercise program for patients with claudication. Patient risk factors were prospectively recorded in a group of patients who had completed 1 year on a supervised exercise program. In 165 claudicant patients, maximum walking distance increased (P < .0001) from 67 meters (range, 17-196) to 122 meters (range, 43-409). Quality of life as measured by the Medical Outcome Study Short Form 36 increased (P < .0001) from a median of 78 (range, 55-110) to 99 (range, 71-154). The improvements in claudication distance, maximal walking distance, and quality of life after the exercise program were not dependent on any of the measured patient factors. Patients referred to exercise programs for claudication are a heterogenous group. Despite this, they benefit equally from such a program.
Fowkes FG , Gillespie INAngioplasty (versus non surgical management) for intermittent claudication . Cochrane Database Syst Rev. 2000;2: CD000017 .
2.
Whyman MR , Fowkes FG , Kerracher EM , et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial . J Vasc Surg.1997;26: 551-557 .
3.
Creasy TS , McMillan PJ , Fletcher EW , Collin J. , Morris PJIs percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial . Eur J Vasc Surg.1990;4: 135-140 .
4.
Treesak C. , Kasemsup V. , Treat-Jacobson D. , Nyman JA , Hirsch ATCost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease . Vasc Med.2004;9: 279-285 .
5.
Turton EP , Coughlin PA , Kester RC , Scott DJExercise training reduces the acute inflammatory response associated with claudication . Eur J Vasc Endovasc Surg.2002 ;23: 309-336 .
6.
Tan KH , De Cossart L. , Edwards PRExercise training and peripheral vascular disease . Br J Surg.2000;87: 553-562 .
7.
Regensteiner JGExercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment . Curr Drug Targets Cardiovasc Haematol Disord.2004;4: 233-239 .
8.
Brandsma JW , Robeer BG , van den Heuvel S. , Smit B. , Wittens CH , Oostendorp RAThe effect of exercises on walking distance of patients with intermittent claudication: a study of randomized clinical trials . Phys Ther.1998;78: 278-286 .
9.
Robeer GG , Brandsma JW , van den Heuvel SP , Smit B. , Oostendorp RA , Wittens CHExercise therapy for intermittent claudication: a review of the quality of randomised clinical trials and evaluation of predictive factors . Eur J Vasc Endovasc Surg.1998;15: 36-43 .
10.
Patterson RB , Pinto B. , Marcus B. , Colucci A. , Braun T. , Roberts M.Value of a supervised exercise program for the therapy of arterial claudication . J Vasc Surg.1997;25: 312-318 .
11.
Scottish Physiotherapy Amputee Research Group (SPARG).SPARG Guidelines: Exercise Therapy for Patients with Intermittent Claudication. Glasgow , UK: SPARG ; 2001.
12.
Regensteiner JG , Treat-Jacobson D. , Walsh ME , et al. Partners: the impact of peripheral arterial disease (PAD) on health-related quality of life (HQL) [Abstract 1948] . Circulation. 2000;102: II-400 .
13.
Danielsson G. , Albrechtsson U. , Norgren L. , et al. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome . Eur J Vasc Endovasc Surg.2001;21: 432-436 .
14.
Jensen LP , Schroeder TV , Lorentzen JEIn situ saphenous vein bypass surgery in diabetic patients . Eur J Vasc Surg.1992;6: 533-539 .
15.
Quick CR , Cotton LTThe measured effect of stopping smoking on intermittent claudication . Br J Surg.1982;69(suppl): 24-26 .
16.
Gardner AW , Killewich LA , Montgomery PS , Katzel LIResponse to exercise rehabilitation in smoking and non-smoking patients with intermittent claudication . J Vasc Surg.2004 ;39: 531-538 .
17.
Cahan MA , Montgomery P. , Otis RB , Clancy R. , Flinn W. , Gardner A.The effect of cigarette smoking status on six-minute walk distance in patients with intermittent claudication . Angiology. 1999;50: 537-546 .
18.
Kudo T. , Chandra FA , Ahn SSLong-term outcomes and predictors of iliac angioplasty with selective stenting . J Vasc Surg.2005;42: 466-475 .
19.
Gentile AT , Mills JL , Gooden MA , et al. Identification of predictors for lower extremity vein graft stenosis . Am J Surg.1997;174: 218-221 .
20.
Barnett AH , Bradbury AW , Brittenden J. , et al. The role of cilostazol in the treatment of intermittent claudication . Curr Med Res Opin. 2004;20: 1661-1670 .
21.
Money SR , Herd JA , Isaacsohn JL , et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease . J Vasc Surg.1998;27: 267-274 .
22.
Aronow WS , Nayak D. , Woodworth S. , Ahn C.Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment . Am J Cardiol.2003;92: 711-712 .
23.
Mondillo S. , Ballo P. , Barbati R. , et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease . Am J Med.2003;114: 359-364 .
24.
Mohler ER3rd, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease . Circulation. 2003;108: 1481-1486 .
